NVS

Novartis AG (NVS)

Last Price$109.41.9%
Market Cap$217.3B
LTM Free Cash Flow margin
27.0%
5Y avg
23.0%
Drug Manufacturers - General industry median
20.3%
Stock quality & Intrinsic value
7/10
0.2% undervalued

Novartis AG Free Cash Flow margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
NVS
Healthcare
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Free Cash Flow margin
20.1%
17.4%
15.6%
17.5%
21.0%
23.0%
20.1%
18.9%
16.0%
19.0%
16.0%
17.4%
19.7%
20.5%
23.4%
22.2%
22.9%
22.3%
25.1%
26.7%
NVS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for NVS and see if it's the right time to invest.
Dive in

Novartis AG (NVS) Free Cash Flow margin comparison analysis

Crunching data... Almost there!

NVS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Novartis AG's Free Cash Flow margin?

As of today, Microsoft Corp's last 12-month Free Cash Flow margin is 27.0%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Free Cash Flow margin for Novartis AG have been 23.1% over the past three years, and 24.2% over the past five years.

2) Is Novartis AG's Free Cash Flow margin Good?

As of today, Novartis AG's Free Cash Flow margin is 27.0%, which is higher than industry median of 20.3%. It indicates that Novartis AG's Free Cash Flow margin is Good.

3) How does Novartis AG's Free Cash Flow margin compare to its peers?

As of today, Novartis AG's Free Cash Flow margin is 27.0%, which is higher than peer median of 24.6%. The list of peers includes GILD, MRK, ABBV, AMGN, BMY, JNJ, AZN, PFE, LLY, SNY.